Annual Current Liabilities
$653.66 M
+$34.05 M+5.50%
31 December 2023
Summary:
Sarepta Therapeutics annual total current liabilities is currently $653.66 million, with the most recent change of +$34.05 million (+5.50%) on 31 December 2023. During the last 3 years, it has risen by +$200.93 million (+44.38%). SRPT annual current liabilities is now at all-time high.SRPT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$699.49 M
+$11.00 M+1.60%
30 September 2024
Summary:
Sarepta Therapeutics quarterly total current liabilities is currently $699.49 million, with the most recent change of +$11.00 million (+1.60%) on 30 September 2024. Over the past year, it has increased by +$45.83 million (+7.01%). SRPT quarterly current liabilities is now at all-time high.SRPT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +7.0% |
| 3 y3 years | +44.4% | +54.5% |
| 5 y5 years | +146.9% | +164.2% |
SRPT Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +44.4% | at high | +55.2% |
| 5 y | 5 years | at high | +146.9% | at high | +164.2% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Sarepta Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $699.49 M(+1.6%) |
| June 2024 | - | $688.49 M(+13.1%) |
| Mar 2024 | - | $608.71 M(-6.9%) |
| Dec 2023 | $653.66 M(+5.5%) | $653.66 M(+45.0%) |
| Sept 2023 | - | $450.74 M(-9.6%) |
| June 2023 | - | $498.65 M(-7.1%) |
| Mar 2023 | - | $536.88 M(-13.4%) |
| Dec 2022 | $619.60 M(+36.9%) | $619.60 M(+2.8%) |
| Sept 2022 | - | $602.92 M(+10.5%) |
| June 2022 | - | $545.57 M(+19.9%) |
| Mar 2022 | - | $454.96 M(+0.5%) |
| Dec 2021 | $452.73 M(+8.8%) | $452.73 M(+21.2%) |
| Sept 2021 | - | $373.44 M(-12.1%) |
| June 2021 | - | $425.02 M(+16.5%) |
| Mar 2021 | - | $364.74 M(-12.3%) |
| Dec 2020 | $416.03 M(+57.1%) | $416.03 M(+9.9%) |
| Sept 2020 | - | $378.39 M(+6.6%) |
| June 2020 | - | $354.90 M(+15.8%) |
| Mar 2020 | - | $306.43 M(+15.7%) |
| Dec 2019 | $264.77 M(+52.4%) | $264.77 M(+22.7%) |
| Sept 2019 | - | $215.86 M(+33.2%) |
| June 2019 | - | $162.09 M(+18.0%) |
| Mar 2019 | - | $137.37 M(-20.9%) |
| Dec 2018 | $173.69 M(+96.6%) | $173.69 M(+51.8%) |
| Sept 2018 | - | $114.39 M(+9.3%) |
| June 2018 | - | $104.69 M(+14.8%) |
| Mar 2018 | - | $91.20 M(+3.2%) |
| Dec 2017 | $88.33 M(+17.1%) | $88.33 M(+25.3%) |
| Sept 2017 | - | $70.47 M(+6.8%) |
| June 2017 | - | $65.96 M(-11.6%) |
| Mar 2017 | - | $74.63 M(-1.1%) |
| Dec 2016 | $75.42 M(+21.1%) | $75.42 M(+16.2%) |
| Sept 2016 | - | $64.93 M(-3.0%) |
| June 2016 | - | $66.93 M(+21.3%) |
| Mar 2016 | - | $55.16 M(-11.5%) |
| Dec 2015 | $62.29 M(+69.0%) | $62.29 M(+65.4%) |
| Sept 2015 | - | $37.67 M(-3.3%) |
| June 2015 | - | $38.96 M(+14.9%) |
| Mar 2015 | - | $33.91 M(-8.0%) |
| Dec 2014 | $36.87 M(+2.5%) | $36.87 M(+62.2%) |
| Sept 2014 | - | $22.73 M(-22.7%) |
| June 2014 | - | $29.40 M(-22.1%) |
| Mar 2014 | - | $37.76 M(+5.0%) |
| Dec 2013 | $35.97 M(-54.4%) | $35.97 M(-29.6%) |
| Sept 2013 | - | $51.10 M(-44.7%) |
| June 2013 | - | $92.43 M(-10.8%) |
| Mar 2013 | - | $103.66 M(+31.4%) |
| Dec 2012 | $78.89 M(+282.9%) | $78.89 M(+42.9%) |
| Sept 2012 | - | $55.20 M(+222.2%) |
| June 2012 | - | $17.13 M(-42.7%) |
| Mar 2012 | - | $29.92 M(+45.3%) |
| Dec 2011 | $20.60 M(-55.1%) | $20.60 M(-22.4%) |
| Sept 2011 | - | $26.53 M(-28.2%) |
| June 2011 | - | $36.94 M(-14.5%) |
| Mar 2011 | - | $43.22 M(-5.8%) |
| Dec 2010 | $45.86 M | $45.86 M(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $43.77 M(+17.4%) |
| June 2010 | - | $37.27 M(+41.5%) |
| Mar 2010 | - | $26.34 M(-21.4%) |
| Dec 2009 | $33.51 M(+359.8%) | $33.51 M(-22.2%) |
| Sept 2009 | - | $43.06 M(+63.8%) |
| June 2009 | - | $26.29 M(+126.3%) |
| Mar 2009 | - | $11.62 M(+59.4%) |
| Dec 2008 | $7.29 M(-25.3%) | $7.29 M(-31.7%) |
| Sept 2008 | - | $10.67 M(+20.8%) |
| June 2008 | - | $8.83 M(-27.3%) |
| Mar 2008 | - | $12.14 M(+24.5%) |
| Dec 2007 | $9.75 M(+209.5%) | $9.75 M(+2.1%) |
| Sept 2007 | - | $9.55 M(+95.4%) |
| June 2007 | - | $4.89 M(+12.4%) |
| Mar 2007 | - | $4.35 M(+38.0%) |
| Dec 2006 | $3.15 M(+14.7%) | $3.15 M(+44.3%) |
| Sept 2006 | - | $2.18 M(-3.6%) |
| June 2006 | - | $2.26 M(+2.5%) |
| Mar 2006 | - | $2.21 M(-19.6%) |
| Dec 2005 | $2.75 M(+22.2%) | $2.75 M(+8.9%) |
| Sept 2005 | - | $2.52 M(+30.9%) |
| June 2005 | - | $1.93 M(-15.4%) |
| Mar 2005 | - | $2.28 M(+1.3%) |
| Dec 2004 | $2.25 M(-40.0%) | $2.25 M(+66.7%) |
| Sept 2004 | - | $1.35 M(-37.7%) |
| June 2004 | - | $2.17 M(-21.2%) |
| Mar 2004 | - | $2.75 M(-26.7%) |
| Dec 2003 | $3.75 M(-26.8%) | $3.75 M(+62.5%) |
| Sept 2003 | - | $2.31 M(+78.1%) |
| June 2003 | - | $1.30 M(-20.0%) |
| Mar 2003 | - | $1.62 M(-68.4%) |
| Dec 2002 | $5.12 M(+56.1%) | $5.12 M(+4.2%) |
| Sept 2002 | - | $4.92 M(+24.3%) |
| June 2002 | - | $3.96 M(-16.2%) |
| Mar 2002 | - | $4.72 M(+43.9%) |
| Dec 2001 | $3.28 M(+90.5%) | $3.28 M(+107.5%) |
| Sept 2001 | - | $1.58 M(-2.0%) |
| June 2001 | - | $1.61 M(-0.2%) |
| Mar 2001 | - | $1.62 M(-6.1%) |
| Dec 2000 | $1.72 M(+72.3%) | $1.72 M(+30.9%) |
| Sept 2000 | - | $1.32 M(+19.2%) |
| June 2000 | - | $1.10 M(+44.0%) |
| Mar 2000 | - | $767.00 K(-23.3%) |
| Dec 1999 | $1.00 M(-16.7%) | $1.00 M(+25.0%) |
| Sept 1999 | - | $800.00 K(+100.0%) |
| June 1999 | - | $400.00 K(-42.9%) |
| Mar 1999 | - | $700.00 K(-41.7%) |
| Dec 1998 | $1.20 M(+140.0%) | $1.20 M(0.0%) |
| Sept 1998 | - | $1.20 M(+200.0%) |
| June 1998 | - | $400.00 K(-20.0%) |
| Mar 1998 | - | $500.00 K(0.0%) |
| Dec 1997 | $500.00 K(+66.7%) | $500.00 K(-37.5%) |
| Sept 1997 | - | $800.00 K(-11.1%) |
| June 1997 | - | $900.00 K(+125.0%) |
| Mar 1997 | - | $400.00 K |
| Dec 1996 | $300.00 K | - |
FAQ
- What is Sarepta Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly current liabilities year-on-year change?
What is Sarepta Therapeutics annual total current liabilities?
The current annual current liabilities of SRPT is $653.66 M
What is the all time high annual current liabilities for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total current liabilities is $653.66 M
What is Sarepta Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of SRPT is $699.49 M
What is the all time high quarterly current liabilities for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total current liabilities is $699.49 M
What is Sarepta Therapeutics quarterly current liabilities year-on-year change?
Over the past year, SRPT quarterly total current liabilities has changed by +$45.83 M (+7.01%)